GB1595021A - Process for the production of antidiarrheal agents - Google Patents

Process for the production of antidiarrheal agents Download PDF

Info

Publication number
GB1595021A
GB1595021A GB340/78A GB34078A GB1595021A GB 1595021 A GB1595021 A GB 1595021A GB 340/78 A GB340/78 A GB 340/78A GB 34078 A GB34078 A GB 34078A GB 1595021 A GB1595021 A GB 1595021A
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical preparation
active ingredient
administration
encephaline
methionine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB340/78A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of GB1595021A publication Critical patent/GB1595021A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB340/78A 1977-01-07 1978-01-05 Process for the production of antidiarrheal agents Expired GB1595021A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU76538A LU76538A1 (no) 1977-01-07 1977-01-07

Publications (1)

Publication Number Publication Date
GB1595021A true GB1595021A (en) 1981-08-05

Family

ID=19728442

Family Applications (1)

Application Number Title Priority Date Filing Date
GB340/78A Expired GB1595021A (en) 1977-01-07 1978-01-05 Process for the production of antidiarrheal agents

Country Status (13)

Country Link
JP (1) JPS5388332A (no)
AU (1) AU3221778A (no)
BE (1) BE862689A (no)
CA (1) CA1109796A (no)
DE (1) DE2800110A1 (no)
FR (1) FR2376663A1 (no)
GB (1) GB1595021A (no)
IE (1) IE46241B1 (no)
IL (1) IL53760A (no)
IT (1) IT7847545A0 (no)
LU (1) LU76538A1 (no)
NL (1) NL7800045A (no)
ZA (1) ZA7887B (no)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2174599A (en) * 1985-04-04 1986-11-12 Norwich Eaton Pharma Furazolidone dosage form
WO1987003485A1 (en) * 1985-12-11 1987-06-18 Vereniging Voor Christelijk Wetenschappelijk Onder Compositions for combatting diarrhoea

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6613332B1 (en) 1991-06-21 2003-09-02 The University Of Cincinnati Oral administration of therapeutic proteins
EP0590060B1 (en) * 1991-06-21 1997-09-17 University Of Cincinnati Orally administrable therapeutic proteins and method of making

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2174599A (en) * 1985-04-04 1986-11-12 Norwich Eaton Pharma Furazolidone dosage form
WO1987003485A1 (en) * 1985-12-11 1987-06-18 Vereniging Voor Christelijk Wetenschappelijk Onder Compositions for combatting diarrhoea

Also Published As

Publication number Publication date
IL53760A0 (en) 1978-04-30
CA1109796A (en) 1981-09-29
IT7847545A0 (it) 1978-01-06
IE46241B1 (en) 1983-04-06
IE780032L (en) 1978-07-07
LU76538A1 (no) 1978-09-18
JPS5388332A (en) 1978-08-03
AU3221778A (en) 1979-07-12
FR2376663B1 (no) 1981-11-20
DE2800110A1 (de) 1978-07-13
FR2376663A1 (fr) 1978-08-04
BE862689A (fr) 1978-07-06
ZA7887B (en) 1978-11-29
NL7800045A (nl) 1978-07-11
IL53760A (en) 1981-07-31

Similar Documents

Publication Publication Date Title
US7374781B2 (en) Sustained release formulations containing acetaminophen and tramadol
US4309404A (en) Sustained release pharmaceutical compositions
CA1264296A (en) Formulations providing three distinct releases
US4424235A (en) Hydrodynamically balanced controlled release compositions containing L-dopa and a decarboxylase inhibitor
KR940000100B1 (ko) 메토프롤롤염을 함유하는 서방형 제제의 제조방법
EP1485078B1 (en) Milnacipran for the treatment of irritable bowel syndrome
CA1303504C (en) Pharmaceutical formulation containing acrivastine
AU2002309429B2 (en) Pharmaceutical formulation for the efficient administration of apomorphine, 6aR-(-)-N-propyl-norapomorphine and their derivatives and pro-drugs thereof
CA1298198C (en) Composition comprising l-dopa
AU610161B2 (en) Layered coatings for pharmaceutical granules
IE850744L (en) Storage-stable, quick-disintegrating pharmaceuticals
CA2509259A1 (en) Sustained-release preparations and method for producing the same
AU2002309429A1 (en) Pharmaceutical formulation for the efficient administration of apomorphine, 6aR-(-)-N-propyl-norapomorphine and their derivatives and pro-drugs thereof
US4668684A (en) Combination of flupirtin and anticholinergic acting spasmolytic
EP0495270B1 (en) Azaribine composition
GB2105590A (en) Flotable controlled release preparations
NO20121414A1 (no) Farmasoytiske sammensetninger omfattende hydromorfon og nalokson
CA2032475C (en) Pharmaceutical preparations for oral administration that are adapted to release the drug at appropriate sites in the intestines
EP1897544A1 (en) Opioid agonist and antagonist combinations
US4180559A (en) Coated 1-(2-chlorodibenzo[b,f]oxepin-10-yl)-4-methylpiperazine compositions
GB1595021A (en) Process for the production of antidiarrheal agents
US5897877A (en) Oral pharmaceutical preparation containing erythromycin base
US4411882A (en) Galenical compositions
GB2038181A (en) Galenical compositions
CA1059914A (en) Pharmaceutical preparation for the treatment of circulatory disorders

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee